Medtronic: Q4 Numbers & What it Means

So, Q4 earnings are out for Medtronic, and while they met expectations, it wasn't exactly a blowout. I'm in the Diabetes group, and we've been hearing a lot about market challenges and competition. The official statements are always positive spin, but reading between the lines, it feels like cost-cutting is inevitable. I haven't seen any official layoff notices, but I'm wondering if anyone has heard anything more specific about departments that might be more vulnerable? Some of the less profitable product lines or areas with significant overlap are always a target during these times. Just trying to get a realistic picture of what the financial reports might signal for job security in the coming months. Anyone in finance or strategy have any insights?